¼¼°èÀÇ °£¿° Ä¡·áÁ¦ ½ÃÀå - ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Áúȯº°, À¯Åë ä³Îº°, Áö¿ªº°, ºÎ¹® ¿¹Ãø(2024-2030³â)
Hepatitis Therapeutics Market Size, Share & Trends Analysis Report By Disease (Hepatitis A, Hepatitis B, Hepatitis C), By Distribution Channel (Hospital Pharmacies), By Region, And Segment Forecasts, 2024 - 2030
»óǰÄÚµå : 1553567
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 100 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,194,000
Unprintable PDF & Excel (Single User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» 1Àθ¸ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,571,000
Printable PDF & Excel (5-User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» µ¿ÀÏ ±â¾÷ ³» µ¿ÀÏ ºÎ¼­¿¡¼­ ÃÖ´ë 5¸í±îÁö »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,325,000
Printable PDF & Excel (Enterprise License) help
º¸°í¼­ ±¸¸Å ±â¾÷ ¹× ±× ÀÚȸ»ç, °ü°è»ç°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀ̸ç, PDF ¹× ¿¢¼¿ ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

°£¿° Ä¡·áÁ¦ ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é °£¿° Ä¡·áÁ¦ ¼¼°è ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 208¾ï 4,000¸¸ ´Þ·¯¿¡ À̸£°í, ¿¹Ãø ±â°£ µ¿¾È CAGR 3.7%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È ½ÃÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ¿äÀÎÀ¸·Î´Â °£¿° °¨¿°ÀÚ ¼ö Áõ°¡, ¾ËÄÚ¿Ã ¹× ¾à¹° ¼Òºñ·® Áõ°¡, °£¿° Ä¡·áÁ¦ Á¢±Ù¼º °³¼± µîÀÌ ÀÖ½À´Ï´Ù.

ȯÀÚ°¡ °íÅë¹Þ´Â ±â°£¿¡ µû¶ó ¹ÙÀÌ·¯½º¼º °£¿°Àº ÀϹÝÀûÀ¸·Î µÎ °¡Áö À¯ÇüÀ¸·Î ºÐ·ùµË´Ï´Ù. Áõ»óÀÌ 6°³¿ù ÀÌÇÏ Áö¼ÓµÇ¸é ±Þ¼º °£¿°, 6°³¿ù ÀÌ»ó Áö¼ÓµÇ´Â °æ¿ì ¸¸¼º °£¿°À¸·Î ºÐ·ùµË´Ï´Ù. HIV °¨¿°ÀÚ¿Í HCV °¨¿°ÀÚÀÇ ¼ºÀû ÆÄÆ®³Ê, °¨¿°µÈ Ç÷¾× ¼ö·ÉÀÎ, ¾à¹° ÁÖ»ç ¹× ºñ°­ ¾à¹°À» »ç¿ëÇϴ ȯÀÚ, ºñÀ§»ý ȯ°æ¿¡¼­ »ýȰÇÏ´Â Áý´ÜÀº °£¿° À§ÇèÀÌ ³ô½À´Ï´Ù.

WHOÀÇ ±âº» ÃßÁ¤¿¡ µû¸£¸é, ¼¼°è¿¡¼­ ¾à 4¾ï ¸íÀÌ Àû¾îµµ ÇϳªÀÇ °£¿°¿¡ °¨¿°µÇ¾úÀ¸¸ç ¿¬°£ ¾à 1.4¸íÀÌ °£¿°À¸·Î ÀÎÇØ »ç¸ÁÇϰí ÀÖ½À´Ï´Ù. °£¿°À» ¿¹¹æÇϱâ À§ÇØ Á¤ºÎ¿Í ¹Î°£ ±â°üÀÌ Àû±ØÀûÀ¸·Î ¿¹¹æ Á¢Á¾¿¡ Á¾»çÇÏ´Â ¿¹´Â Àû½À´Ï´Ù. AÇü °£¿°°ú BÇü °£¿°¿¡ ºñÇØ HCV´Â ´õ ½É°¢ÇÑ ÇÕº´ÁõÀ» À¯¹ßÇÕ´Ï´Ù. WHOÀÇ ÃßÁ¤¿¡ µû¸£¸é, ¼¼°è¿¡¼­´Â ¸Å³â 1¾ï 5,000¸¸ ¸íÀÌ CÇü °£¿°ÀÇ °¨¿°¿¡ ÀÇÇØ ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡ HCV °¨¿°ÀÚÀÇ ´ëºÎºÐÀº °£¾ÏÀ̳ª °£°æº¯À» ¹ßº´ÇØ 70¸¸¸í °¡±îÀÌ CÇü °£¿° °¨¿°°ú °ü·Ã ÁúȯÀ¸·Î »ç¸ÁÇϰí ÀÖ½À´Ï´Ù.

°£¿° Ä¡·áÁ¦ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå °£¿° Ä¡·áÁ¦ ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå °£¿° Ä¡·áÁ¦ ½ÃÀå : Áúȯº°, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦5Àå °£¿° Ä¡·áÁ¦ ½ÃÀå : À¯Åë ä³Îº°, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦6Àå °£¿° Ä¡·áÁ¦ ½ÃÀå :Áö¿ªº°, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦7Àå °æÀï ±¸µµ

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Hepatitis Therapeutics Market Growth & Trends:

The global hepatitis therapeutics market size is expected to reach USD 20.84 billion by 2030, registering a CAGR of 3.7% during the forecast period, according to a new report by Grand View Research, Inc. Few factors that are expected to drive the market over the forecast period include the rising number of hepatitis infected population, growing consumption of alcohol & drugs, and improving accessibility to hepatitis drugs.

Based on the duration for which the patient suffers, viral hepatitis is generally categorized into two types. If the condition lasts for less than six months, then it is classified as acute, when the condition persists for more than six months, then it is a case of chronic hepatitis. People with HIV infection & HCV-infected sexual partners, recipients of infected blood, patients who inject drugs & use intranasal drugs, and population groups who live in unhygienic conditions are at high risk of hepatitis.

Based on the estimates of WHO, approximately 400 million people are infected with at least one form of hepatitis globally, and annually nearly 1.4 people die due to the condition. In order to prevent hepatitis, few government and private agencies are actively involved in the vaccination drive to prevent hepatitis. As compared to hepatitis A and B, HCV leads to more serious complications. According to the estimates of WHO, globally annually 150 million are impacted by hepatitis C infection. Moreover, the majority of HCV infected patients develop liver cancer or liver cirrhosis and nearly 700,000 people die due to hepatitis C infection & associated conditions.

Hepatitis Therapeutics Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Hepatitis Therapeutics Market Variables, Trends, & Scope

Chapter 4. Hepatitis Therapeutics Market: Disease Estimates & Trend Analysis

Chapter 5. Hepatitis Therapeutics Market: Distribution Channel Estimates & Trend Analysis

Chapter 6. Hepatitis Therapeutics Market: Regional Estimates & Trend Analysis

Chapter 7. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â